Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Current Assets (2016 - 2025)

Historic Current Assets for Catalyst Pharmaceuticals (CPRX) over the last 16 years, with Q3 2025 value amounting to $852.5 million.

  • Catalyst Pharmaceuticals' Current Assets rose 5815.51% to $852.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $852.5 million, marking a year-over-year increase of 5815.51%. This contributed to the annual value of $623.6 million for FY2024, which is 18432.58% up from last year.
  • As of Q3 2025, Catalyst Pharmaceuticals' Current Assets stood at $852.5 million, which was up 5815.51% from $758.7 million recorded in Q2 2025.
  • Over the past 5 years, Catalyst Pharmaceuticals' Current Assets peaked at $852.5 million during Q3 2025, and registered a low of $161.5 million during Q1 2021.
  • For the 5-year period, Catalyst Pharmaceuticals' Current Assets averaged around $368.0 million, with its median value being $242.6 million (2022).
  • Its Current Assets has fluctuated over the past 5 years, first crashed by 3163.19% in 2023, then soared by 18432.58% in 2024.
  • Catalyst Pharmaceuticals' Current Assets (Quarter) stood at $210.1 million in 2021, then surged by 52.69% to $320.8 million in 2022, then crashed by 31.63% to $219.3 million in 2023, then soared by 184.33% to $623.6 million in 2024, then soared by 36.7% to $852.5 million in 2025.
  • Its Current Assets was $852.5 million in Q3 2025, compared to $758.7 million in Q2 2025 and $685.7 million in Q1 2025.